Anthony E Hitch1, Nicole K Gause2, Jennifer L Brown3. 1. Department of Psychology, University of Cincinnati, 3131 Harvey Avenue, Suite 104, Cincinnati, OH, 45208, USA. hitchae@mail.uc.edu. 2. Department of Psychology, University of Cincinnati, 3131 Harvey Avenue, Suite 104, Cincinnati, OH, 45208, USA. 3. Addiction Sciences Division, Department of Psychiatry & Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Abstract
PURPOSE OF REVIEW: People living with human immunodeficiency virus/AIDS (PLWHA) experience high prevalence of substance use disorders (SUD). HIV care settings represent a unique opportunity to identify possible SUD, to provide SUD interventions, and to improve linkage to SUD treatment. The aims of this paper are to (a) review and critique the extant literature examining substance use screening approaches among PLWHA in HIV care settings and (b) provide recommendations for future clinical practice. RECENT FINDINGS: Twenty-one peer-reviewed articles that examined substance screening approaches employed in HIV and other primary care settings were included in the review. There was limited literature reporting on the implementation and evaluation of substance use screening practices within HIV care settings, and methodological rigor varied across studies. Further, the use of validated substance use screening measures or incorporation of other substance use screening approaches (e.g., use of urine drug testing) within routine HIV care practice is limited. Strategies to implement routine substance use screening within HIV care and incorporate additional substance use assessment, brief interventions, and referral to specialty substance use treatment are discussed. Use of self-report substance use screening measures using web- or computer-delivered approaches that can be integrated within electronic health record systems is particularly promising. HIV care practices should consider potential models to optimally screen and treat SUD. Co-location of HIV and SUD treatment services may be optimal; when co-located services are not possible, strategies to consistently provide brief intervention approaches and referrals to specialty SUD treatment are needed.
PURPOSE OF REVIEW: People living with human immunodeficiency virus/AIDS (PLWHA) experience high prevalence of substance use disorders (SUD). HIV care settings represent a unique opportunity to identify possible SUD, to provide SUD interventions, and to improve linkage to SUD treatment. The aims of this paper are to (a) review and critique the extant literature examining substance use screening approaches among PLWHA in HIV care settings and (b) provide recommendations for future clinical practice. RECENT FINDINGS: Twenty-one peer-reviewed articles that examined substance screening approaches employed in HIV and other primary care settings were included in the review. There was limited literature reporting on the implementation and evaluation of substance use screening practices within HIV care settings, and methodological rigor varied across studies. Further, the use of validated substance use screening measures or incorporation of other substance use screening approaches (e.g., use of urine drug testing) within routine HIV care practice is limited. Strategies to implement routine substance use screening within HIV care and incorporate additional substance use assessment, brief interventions, and referral to specialty substance use treatment are discussed. Use of self-report substance use screening measures using web- or computer-delivered approaches that can be integrated within electronic health record systems is particularly promising. HIV care practices should consider potential models to optimally screen and treat SUD. Co-location of HIV and SUD treatment services may be optimal; when co-located services are not possible, strategies to consistently provide brief intervention approaches and referrals to specialty SUD treatment are needed.
Entities:
Keywords:
HIV/AIDS; Primary care; Screening; Screening, brief intervention, and referral to treatment (SBIRT); Substance use
Authors: Joel Swendsen; Kevin P Conway; Louisa Degenhardt; Meyer Glantz; Robert Jin; Kathleen R Merikangas; Nancy Sampson; Ronald C Kessler Journal: Addiction Date: 2010-03-10 Impact factor: 6.526
Authors: Don C Des Jarlais; Kamyar Arasteh; Theresa Perlis; Holly Hagan; Abu Abdul-Quader; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Chris Nemeth; Lucia V Torian; Samuel R Friedman Journal: AIDS Date: 2007-01-11 Impact factor: 4.177
Authors: Brian Wells Pence; Bradley N Gaynes; Kathryn Whetten; Joseph J Eron; Robert W Ryder; William C Miller Journal: J Acquir Immune Defic Syndr Date: 2005-12-01 Impact factor: 3.731
Authors: Judith A Cook; Jane K Burke-Miller; Mardge H Cohen; Robert L Cook; David Vlahov; Tracey E Wilson; Elizabeth T Golub; Rebecca M Schwartz; Andrea A Howard; Claudia Ponath; Michael W Plankey; Alexandra M Levine; Andrea Levine; Dennis D Grey Journal: AIDS Date: 2008-07-11 Impact factor: 4.177
Authors: Adam W Carrico; Mallory O Johnson; Judith T Moskowitz; Torsten B Neilands; Stephen F Morin; Edwin D Charlebois; Wayne T Steward; Robert H Remien; F Lennie Wong; Mary Jane Rotheram-Borus; Marguerita A Lightfoot; Margaret A Chesney Journal: Psychosom Med Date: 2007-10-17 Impact factor: 4.312
Authors: Seth C Kalichman; Christopher Washington; Christopher Kegler; Tamar Grebler; Moira O Kalichman; Chauncey Cherry; Lisa Eaton Journal: Subst Use Misuse Date: 2015-11-19 Impact factor: 2.164
Authors: Bryan R Garner; Hannah K Knudsen; Brittany A Zulkiewicz; Stephen J Tueller; Heather J Gotham; Erika G Martin; Tom Donohoe; Alyssa K Toro; Katie Loyd; Theodore Gordon Journal: J Acquir Immune Defic Syndr Date: 2022-07-01 Impact factor: 3.771
Authors: Sarah M Jabour; Geetanjali Chander; Kristin A Riekert; Jeanne C Keruly; Kayla Herne; Heidi Hutton; Mary Catherine Beach; Bryan Lau; Richard D Moore; Anne K Monroe Journal: AIDS Behav Date: 2021-02-09
Authors: Kathleen A McGinnis; Melissa Skanderson; Amy C Justice; Kathleen M Akgün; Janet P Tate; Joseph T King; Christopher T Rentsch; Vincent C Marconi; Evelyn Hsieh; Christopher Ruser; Farah Kidwai-Khan; Roozbeh Yousefzadeh; Joseph Erdos; Lesley S Park Journal: J Int AIDS Soc Date: 2021-10 Impact factor: 5.396
Authors: Deborah Konkle-Parker; Daniel Williams; Nicholas McAfee; Julie A Schumacher; Jefferson Parker Journal: J Behav Health Serv Res Date: 2022-08-10 Impact factor: 1.475
Authors: Angela M Parcesepe; Kathryn Lancaster; E Jennifer Edelman; Raquel DeBoni; Jeremy Ross; Lukoye Atwoli; Mpho Tlali; Keri Althoff; Judicaël Tine; Stephany N Duda; C William Wester; Denis Nash Journal: PLoS One Date: 2020-08-27 Impact factor: 3.240